Glucagon-like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Naïve Patients with Type 2 Diabetes Mellitus: A Multinational Preference Study

INTRODUCTION: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) differ in efficacy, side effects, dosing frequency, and device-related attributes. This study assessed the relative importance of treatment-related attributes in influencing preferences for GLP-1RAs among injection-naïve patients wit...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Diabetes Ther
Glavni autori: Qin, Lei, Chen, Stephanie, Flood, Emuella, Shaunik, Alka, Romero, Beverly, de la Cruz, Marie, Alvarez, Cynthia, Grandy, Susan
Format: Artigo
Jezik:Inglês
Izdano: Springer Healthcare 2017
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5380493/
https://ncbi.nlm.nih.gov/pubmed/28155131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-017-0230-2
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items